Showing results (21-30 of 53) with videos related to
Sort By:
Pageof 6
Tissue & Cell|December 9, 2025
U0126 induces osteoclast differentiation via the p38-NFATc-1 signaling pathwayJiran Wang, Jinan Liu, Xueting Jia, et al.Current Medical Research and Opinion|March 31, 2017
Demographic and clinical profiles of type 2 diabetes mellitus patients initiating sitagliptin in the real-world settingManjiri Pawaskar, Jinan Liu, Swapnil Rajpathak, et al.Dermatology and Therapy|March 7, 2024
Satisfaction with Control of Mild to Moderate Atopic Dermatitis with Ruxolitinib Cream: US Physician and Patient PerspectivesLawrence F Eichenfield, Jinan Liu, Simran Marwaha, et al.Dermatology and Therapy|May 16, 2024
Patient Burden of Nonsegmental Vitiligo: A US Real-World Survey of Dermatologists and Their PatientsDavid Rosmarin, Jennifer H Lofland, Simran Marwaha, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 5, 2018
Retrospective Cohort Analysis of the Reduced Burden of Hypoglycemia Associated with Dipeptidyl Peptidase-4 Inhibitor Use in Patients with Type 2 Diabetes MellitusYuexin Tang, Jinan Liu, Hakima Hannachi, et al.American Health & Drug Benefits|February 7, 2018
The Effects of a Sitagliptin Formulary Restriction Program on Diabetes Medication UseYuexin Tang, Xingyue Huang, Jinan Liu, et al.Clinicoeconomics and Outcomes Research : CEOR|February 11, 2025
Atopic Dermatitis Treatments Before and After Initiation of Ruxolitinib Cream: 6-Month Follow-Up Analysis of a US Payer Claims DatabaseJinan Liu, Karishma Desai, Chia-Chen Teng, et al.Cardiology and Therapy|August 22, 2019
Cardiovascular Risk Factors and Secondary Events Among Acute and Chronic Stable Myocardial Infarction Patients: Findings from a Managed Care DatabaseLori D Bash, Kellee White, Mehul D Patel, et al.Journal of Managed Care & Specialty Pharmacy|October 1, 2021
Budget impact analysis of niraparib for first-line maintenance therapy in advanced ovarian cancer from a US payer perspectiveJinan Liu, Carol Hawkes, Lydia Walder, et al.Dermatology and Therapy|November 25, 2025
Use of Ruxolitinib Cream Results in Economic Benefits Compared with Dupilumab in Treatment of Patients with Atopic Dermatitis Meeting Severity Thresholds for Systemic TherapyOmar Noor, Jinan Liu, Daniel Sturm, et al.Pageof 6